DRMA insider transaction filings
Dermata Therapeutics, Inc. — 17 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-18. Screen DRMA transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | Van Hoose Kyri K. — SVP, CFO | Grant/award (A): 102,040 · Grant/award (A): 102,040 (derivative) · Grant/award (A): 102,040 (derivative) | EDGAR |
| 2026-08-18 | 4 | PROEHL GERALD T — PRESIDENT, CHAIRMAN, CEO, Director, 10% owner | Grant/award (A): 170,068 · Grant/award (A): 1,360,544 (derivative) · Grant/award (A): 1,360,544 (derivative) · Grant/award (A): 170,068 (derivative) · Grant/award (A): 170,068 (derivative) · Grant/award (A): 1,360,544 (derivative) | EDGAR |
| 2026-06-16 | 4 | Scott Kathleen D. — Director | Sale (S): 11 @ $1.19 | EDGAR |
| 2026-03-17 | 4 | Bedoya-Toro Munera Maria E — SVP, Regulatory Affairs | Purchase (P): 1,000 @ $1.27 | EDGAR |
| 2026-01-06 | 4 | Van Hoose Kyri K. — SVP, CFO | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Nardo Christopher J. — Senior VP, CDO | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Bradrick Brittany — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Scott Kathleen D. — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Sandler Andrew Seth — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Bedoya-Toro Munera Maria E — SVP, Regulatory Affairs | Grant/award (A): 9,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Mento Steven J — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | PROEHL GERALD T — President, CEO and Chairman, Director, 10% owner | Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | FISHER MARY — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | WIERENGA WENDELL — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | HALE DAVID F — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | Van Hoose Kyri K. — SVP, CFO | Grant/award (A): 122,549 · Grant/award (A): 122,549 (derivative) · Grant/award (A): 122,549 (derivative) · Disposition to issuer (D): 7,874 (derivative) · Grant/award (A): 7,874 (derivative) | EDGAR |
| 2025-12-29 | 4 | PROEHL GERALD T — PRESIDENT, CHAIRMAN, CEO, Director, 10% owner | Grant/award (A): 490,196 · Grant/award (A): 122,549 · Grant/award (A): 490,196 (derivative) · Grant/award (A): 490,196 (derivative) · Grant/award (A): 122,549 (derivative) · Grant/award (A): 122,549 (derivative) · +2 more | EDGAR |
Recent 8-K events — Dermata Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-17 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-05 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-27 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-25 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-02-03 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-27 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=DRMA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →